Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
Kurt Busch, a director of Mobix Labs, Inc. (MOBX), reported awards and existing holdings on a Form 4 dated with transactions on 09/23/2025. The filing shows 46,855 restricted stock units (RSUs) were granted to Mr. Busch on 09/23/2025, increasing his beneficial ownership to 372,429 shares of Class A common stock.
The report also lists two fully vested, exercisable stock options held directly by Mr. Busch: an option to buy 20,000 shares at an exercise price of $4.18 (expiration 08/10/2030) and an option to buy 133,416 shares at $6.84 (expiration 04/04/2032). The Form 4 was signed by an attorney-in-fact, Terri Aprati, on 09/25/2025.
Mobix Labs insider report: Director David J. Aldrich received 46,855 Restricted Stock Units on September 23, 2025 that will vest on October 1, 2025, and acquired the RSUs at no cash cost. Following that grant, he beneficially owns 289,744 shares of Class A common stock.
Derivative holdings: The filing discloses two fully vested, exercisable stock options: 20,000 options with a $4.18 exercise price (expiring 08/10/2030) and 133,416 options with a $6.84 exercise price (expiring 04/04/2032). The form was signed by an attorney-in-fact on September 25, 2025.
Mobix Labs insider ownership and awards disclosed in Schedule 13D. Keyvan Samini and related trusts report beneficial ownership of 3,316,733 shares of Class A common stock (including 125,000 Class B shares convertible into Class A), representing 5.6% of voting power based on the stated share counts. The filing describes acquisition of Class A shares, options and a grant of 2,550,000 restricted stock awards to Samini on May 5, 2025, which vest over two years and may accelerate at certain stock-price thresholds. Samini is President, CFO and a director of the issuer; employment agreements and multiple equity awards and RSUs are summarized and incorporated by reference.
MOBIX LABS, INC. director Bill Carpou reported a sale of 19,953 shares of Class A common stock on 09/12/2025 at an average price of approximately $0.9418 per share, reducing his direct holdings to 252,167 shares. The filing also shows two fully vested options: one exercisable at $4.18 per share covering 20,000 underlying shares (expires 08/10/2030) and another at $6.84 covering 133,416 shares (expires 04/04/2032). The report was signed by an attorney-in-fact on 09/16/2025 and includes an explanation that sale prices ranged from $0.9418 to $0.9419 and that option grants are fully vested and exercisable.
MOBIX Labs, Inc. (MOBX) filed an S-1 that discloses its post-merger financial position, material financing transactions and near-term liquidity risk. The company completed a business combination and began trading on Nasdaq under MOBX and MOBXW, received a $19,750 PIPE at $10.00 per share and raised net proceeds of $3,645 in an April 2025 offering. For the nine months ended June 30, 2025 the condensed statements show a net loss of $30,402 and an accumulated deficit of $134,859. Management states there is substantial doubt about going concern, citing inadequate liquidity beyond ~ninety days and the need for additional debt or equity financing.
Mobix Labs, Inc. entered into a warrant exercise inducement agreement under which a warrant holder agreed to exercise Existing Warrants for cash to purchase up to 5,486,467 shares of common stock at $0.8202 per share, and in return will receive new Inducement Warrants to buy up to 8,229,701 additional shares.
The company expects aggregate gross proceeds of approximately $4.5 million from these cash exercises. It will pay Roth Capital Partners a 7.0% cash fee on the proceeds and issue Roth Placement Agent Warrants to purchase up to 384,053 shares at $1.08 per share. The Inducement Warrants will have a $1.08 exercise price, become exercisable upon stockholder approval, and remain exercisable for five years.
The Inducement Warrants include 4.99% and 9.99% ownership caps, cashless exercise if no effective registration is available, and Black Scholes-based cash redemption rights in certain fundamental transactions. Mobix agreed to seek stockholder approval within 60 days after the closing date and to limit new issuances and registrations for 45 days, and it extended the termination date of certain unexercised Series B warrants to April 3, 2030.
Mobix Labs, Inc. reported several financing deals that add short-term funding but also introduce potential dilution and collateral pledges. The company issued a secured promissory note to Lendspark Corporation for $550,000, bearing fixed interest and maturing in 12 months, which is convertible at Lendspark’s option at any time into up to 2,500,000 shares of Class A common stock at $0.70 per share. Mobix also provided a first-priority security interest in substantially all of its and its subsidiaries’ assets and issued 150,000 commitment shares, with additional “make-whole” share or cash obligations in certain cases.
Through a separate Business Loan and Security Agreement with Maximcash Solutions LLC, Mobix received $600,000 secured by all company assets and issued 93,750 commitment shares while pledging 1,500,000 shares as collateral, usable only on default. In addition, an accredited investor purchased 1,052,725 shares at $0.95 per share, for roughly $1.0 million in gross proceeds, and received a three-year warrant for 500,045 shares at $0.96 per share. All securities were issued under private offering exemptions from registration.
Mobix Labs, Inc. entered into several debt and equity financing arrangements that add new capital and increase secured obligations. The company issued a $550,000 secured promissory note to Lendspark Corporation, bearing a fixed annual interest rate and maturing in 12 months, and provided a first-priority security interest in substantially all assets. As consideration, it issued 150,000 Class A common shares and allowed the note to convert upon default into up to 2,500,000 Class A shares at a fixed $0.70 per share, with additional "make-whole" share or cash provisions.
The company also obtained a $600,000 loan from Maximcash Solutions LLC, secured by all assets, issuing 93,750 Class A shares as commitment shares and pledging 1,500,000 additional Class A shares as collateral usable only on default. Separately, Mobix sold 1,052,725 Class A shares to an accredited investor at $0.95 per share for approximately $1.0 million in gross proceeds and granted a three-year warrant for 500,045 shares at $0.96 per share. All securities were issued under private placement exemptions.
Mobix Labs, Inc. reported that its Board appointed Chief Executive Officer Philip Sansone as a Class I director, effective immediately, with a term running until the 2028 Annual Meeting of Stockholders. Mr. Sansone has led the Company as CEO after previously serving as Interim CEO and Vice President of Worldwide Sales, and earlier held senior sales roles at MaxLinear. The filing notes there are no appointment arrangements or family relationships between Mr. Sansone and other directors or executive officers. On August 13, 2025, Mr. Sansone, in his capacity as CEO and Director, personally guaranteed a loan to the Company with a principal amount of $600,000, and the filing states he is not involved in any other related-party transactions requiring disclosure.
Samini Keyvan, who serves as President, CFO and a director of Mobix Labs, Inc. (MOBX), reported transactions dated 05/30/2025. The filing shows a disposition of 2,868,204 shares of Class A common stock and discloses several insider awards and holdings intended as compensation and retention.
The reporting person holds or controls derivative and contingent interests including 323,529 exercisable options with a $0.17 exercise price expiring 08/10/2030, 333,333 restricted stock units that convert one-for-one and vest on 12/21/2025, and 915,033 Class B restricted stock awards granted 05/30/2025 that vest over five years. Certain shares are held indirectly through named trusts with amounts disclosed.